New study checks multiple sclerosis drug levels in breast milk
NCT ID NCT06143514
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 34 times
Summary
This study looks at how much of the multiple sclerosis drug BRIUMVI gets into breast milk. Researchers will collect milk samples from 16 breastfeeding women who already take BRIUMVI for relapsing MS. The goal is to understand drug exposure for nursing infants, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSING MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
PROVIDE Virtual Research Coordination Center
RECRUITINGSan Francisco, California, 94158, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
PROVIDE Virtual Research Coordination Center
RECRUITINGSmyrna, Georgia, 30080, United States
-
PROVIDE Virtual Research Coordination Center
RECRUITINGWilmington, North Carolina, 28401-3331, United States
-
PROVIDE Virtual Research Coordination Center
RECRUITINGNashville, Tennessee, 37215, United States
-
TG Therapeutics Investigational Trial Site
RECRUITINGBoston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.